LIVE: FDA Cellular, Tissue, and Gene Therapies Advisory Committee Meets on Biologics License for Deramiocel(Day 2)

Live News Network
1.4K followers
Jul 30, 2026
The FDA Cellular, Tissue, and Gene Therapies Advisory Committee meets at 9:30 a.m. ET on July 30 to discuss and make recommendations on Biologics License Application 125842 from Capricor Inc. for Deramiocel (human allogeneic cardiosphere-derived cells) in the treatment of cardiomyopathy in Duchenne muscular dystrophy.
AI Generated·May contain errors
